Introduction
============

Keratinized gingiva extends from the gingival margin to the muco-gingival junction and is a specialized mucosa that maintains the underlying osseous stability and a healthy dentogingival junction ([@b1-etm-0-0-6979]). Recently in clinical practice, soft tissue augmentation procedures have received increasing attention due to their benefits. Thus, gingival augmentation improves patient comfort, prevents recession of the gingiva, and facilitates plaque control of teeth where plaque accumulation leads to inflammation of the surrounding tissues and mucosal recession ([@b2-etm-0-0-6979],[@b3-etm-0-0-6979]). On the other hand, the use of collagen matrices instead of connective tissue grafts for root coverage results in good healing and significantly reduced recession ([@b4-etm-0-0-6979]). Various surgical methods and materials have been described in the literature, but the most frequent is the repositioned flap and application of an autogenous free gingival graft or subepithelial connective tissue graft harvested from the palatal mucosa ([@b5-etm-0-0-6979]). Acellular dermal matrix grafts and human-derived dermal substitutes were initially proposed as viable alternatives ([@b6-etm-0-0-6979],[@b7-etm-0-0-6979]). A two-layer recombinant xenogeneic collagen matrix and a porcine-derived dermal matrix have been used more recently, with good results for augmenting keratinized tissue and recession coverage procedures in teeth and dental implants ([@b8-etm-0-0-6979],[@b9-etm-0-0-6979]).

Wound healing following periodontal surgery and placement of the collagen matrix is a complex process, where a multitude of factors, including the immune system, interact ([@b10-etm-0-0-6979]). Many factors can modulate the regeneration outcome of the oral mucosa once the immune system contacts the collagen matrix. Among these, T cells are one of the most important immune cellular effectors, and their role in wound healing has been described in detail in the oral cavity as well as other organs and tissues ([@b11-etm-0-0-6979]--[@b13-etm-0-0-6979]). T cells accumulate in the skin and oral mucosa early after a wound occurs or is created, and specific ablation of these cells results in delayed wound re-epithelialization and kinetics of wound closure ([@b14-etm-0-0-6979]).

However, the molecular interactions between these matrices, the surrounding tissues, and their cellular components, such as keratinocytes and immune cells, have not been fully explored. In a previous study, we showed that resorbable collagen matrices stimulate the healing process post-surgery, allowing the formation of new oral epithelia, while being incompletely integrated into the newly formed soft tissue ([@b15-etm-0-0-6979]). To the best of our knowledge there are no studies that explored the interactions between a resorbable three-dimensional (3D) collagen matrix and T cells. Previous experimental models showed that activation of the immune system, particularly T cells, is required for optimal healing following wounds ([@b16-etm-0-0-6979]) or surgery in the oral cavity. Therefore, studies to explore the interactions between the immune system and the collagen matrix are mandated.

The aim of the present study was to investigate the effect of a resorbable 3D collagen matrix on activation of autologous primary T cells and activation-induced cell death in these cells.

Materials and methods
=====================

### Patient selection

The present study was designed as a pilot study of five patients selected from subjects under treatment at the Department of Periodontology of the Victor Babes University of Medicine and Pharmacy, Timisoara, Romania. All patients met several inclusion criteria: Young adults with no local or systemic diseases and not taking any medication over the past 6 months prior to the study. The exclusion criteria included smokers, pregnancy, chronic or acute inflammatory disease or infection, past alcohol abuse, active periodontal disease, and allergies. The protocol and patient informed consent process were approved by the Commission of Research Ethics of the 'Victor Babes' University of Medicine and Pharmacy of Timisoara, Romania (Timisoara, Romania), and written informed consent was obtained from all patients.

### Isolation of mononuclear cells from peripheral venous blood

Samples of peripheral venous blood were collected from subjects in anticoagulant (heparin 15,000 IU/5 ml; Biochemie GmbH, Kundl, Austria). The peripheral blood mononuclear cells (PBMCs) were separated from peripheral blood by centrifugation on a Ficoll-Paque™ Plus (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) gradient. The blood samples were transferred to 16 ml Falcon (Becton-Dickinson, Brea, CA, USA) sterile tubes and diluted at 1:1 with PBS. Each sample was transferred to a 50 ml Falcon sterile tube with Ficoll-Paque, so that the ratio of the diluted sample: Ficoll was 1:1. The transfer of diluted biological samples over the Ficoll layer was gentle, without mixing the two components, allowing the formation of a density gradient. The samples were centrifuged at 400 × g for 30 min. After centrifugation, the ring of mononuclear cells at the interface of the components was harvested and moved to a sterile tube. This step was followed by two successive washes with PBS and consecutive centrifugations at 100 × g for 10 min. After the second centrifugation, the supernatant was removed, and the cell pellet was used for further analysis, or frozen at −80°C (or −196°C) and kept for further investigation.

### 3D collagen matrix

PBMCs were seeded on a fully resorbable 3D collagen matrix specially designed for soft tissue regeneration (Geistlich Mucograft^®^; Geistlich Pharma AG, Wolhusen, Switzerland). This collagen matrix is routinely used for various periodontal surgical procedures in the Department of Periodontology of the Victor Babes University of Medicine and Pharmacy.

### In vitro growth of PBMCs

The PBMCs were cultured for 48 h in T cell expansion Stemline media (Sigma-Aldrich; Merck KGaA; Darmstadt, Germany), supplemented, as specified by the producer, with 10 ml of 200 mM L-glutamine/500 ml medium to increase the T cell population. After 48 h of *in vitro* culture, the cells (1×10^5^ T cells/mm^3^) were placed in contact with the 3D collagen matrix and were transferred to 24-well plates. A comparative analysis was performed between the cells in contact with the 3D collagen matrix and untreated cells.

### Viability tests - Annexin V/propidium iodide (PI)

The Annexin V/PI method was used in order to detect late apoptosis. This assay measures changes in the plasma membrane using Annexin V labeled with a fluorochrome, which binds specifically to phosphatidylserine normally present on the internal face of the plasma membrane. In accordance with the manufacturer\'s recommendations, 1×10^6^ cells were counted using a hemocytometer, washed in 1X Annexin V Binding Buffer (BD Pharmingen, San Diego, CA, USA), centrifuged at 300 × g for 10 min, resuspended in the same solution, and incubated in 10 ml of Annexin V-FITC for 15 min in the dark. After washing the cells with 1 ml of specific buffer followed by centrifugation, the cell pellet was resuspended in 500 µl of binding buffer, and a 1 µg/ml PI solution was added before the flow cytometric analysis. Data acquisition was performed with FACSCalibur flow cytometer and the data analysis was performed using Flow Software 2.5 (Becton-Dickinson).

### Immunophenotyping analysis of T cells by flow cytometry

A lymphocyte immunophenotyping analysis was carried out for the lymphocytes cultured in the main culture medium which represented the control cells, as well as for lymphocytes that were in contact with the collagen matrix for 5 days which represented our target cells. Surface markers were evaluated by flow cytometry after preparing the cells for this purpose. The cells (10^5^ cells/ml) were washed in PBS, resuspended in PBS, and incubated for 30 min in the dark with fluorochrome-conjugated monoclonal antibodies using the manufacturer\'s recommended dilutions. After washing with a specific solution (Cell Wash Solution; BD Biosciences, San Diego, CA, USA), the cells were resuspended in 500 µl Cell Wash and analyzed with a FACSCalibur flow cytometer. Data were acquired using CellQuest Pro software (Becton-Dickinson), and the data analysis was performed using Flow Software 2.5. The primary antibodies conjugated with fluorochromes (BD Pharmingen) used for immunophenotyping characterization of the PBMCs were: CD3 (FITC)/CD16 + 56 (PE)/CD45 (PerCP)/CD19 (APC); CD3 (FITC)/CD8 (PE)/CD45 (PerCP)/CD4 (APC); CD25 (FITC)/CD38 (PE); and CD69 (FITC)/CD166 (PE).

### Statistical analysis

All data are representative of three separate experiments. The statistical analysis was performed using the PASW Statistics 18.0 software (SPSS Inc., Chicago, IL, USA). The paired t-test was used to analyze the differences between the two groups. P-values \<0.05 were considered to indicate statistically significant differences.

Results and Discussion
======================

### Comparative immunophenotyping analysis between unstimulated T cells (control) and collagen matrix-activated T cells

A comparative analysis was performed between cells in contact with the 3D collagen matrix and a control group of cells. As shown in [Fig. 1](#f1-etm-0-0-6979){ref-type="fig"} for CD3^+^ and in [Fig. 3](#f3-etm-0-0-6979){ref-type="fig"} for CD8^+^, both cytotoxic T cell groups were increased significantly due to contact with the collagen matrix, compared to lymphocytes cultured in growth medium. Growth was seen in all samples, regardless of the initial immune status of the subject from which the blood sample was taken. Thus, the flow cytometry analysis showed values of 31.9±6.5 vs. 38.7±3.8% for T cells in the control vs. collagen samples, respectively.

As illustrated in [Figs. 2](#f2-etm-0-0-6979){ref-type="fig"} and [3](#f3-etm-0-0-6979){ref-type="fig"}, the CD69 surface marker increased significantly on the surface of T cells in contact with the collagen matrix (19.7±3.0 vs. 27.1±4.5% for control and collagen sample group, respectively).

The present results showed inter-individual variations in expression of CD38 surface marker, but \>50% of the samples demonstrated decreased expression during contact of lymphocytes with the collagen matrix (50.3±3.0 vs. 46.8±9.1% for controls and collagen samples, respectively; P\>0.05; no statistical significance) ([Fig. 3](#f3-etm-0-0-6979){ref-type="fig"}).

At the same time, CD8 increased significantly (20.7±5.5 vs. 30.7±12.1% in controls vs. collagen samples; P\<0.05), but no difference was found in the CD4 lymphocytes (7.4±2.2 vs. 7.1±3.3%; P\>0.05). Both CD4 and CD8 cells are usually found in the wound bed at all stages of the wound healing process and are particularly involved in late stages of inflammation and early stages of tissue remodeling and proliferation.

### Apoptosis and viability levels following T cell contact with the 3D collagen matrix

As shown in [Fig. 4](#f4-etm-0-0-6979){ref-type="fig"}, the 3D matrix induced no significant apoptotic cell death in T cells, compared to their respective controls. Moreover, the percentages of viable and dead cells were similar in both samples. A comparative analysis was performed between the cells in contact with the 3D collagen matrix and the control group cells (viable cells: 81.2±11.1 vs. 78.5±13.9% in the control vs. collagen groups; P\<0.05), whereas necrotic/late apoptotic cells were 18.5±11.1 vs. 21.2±13.9% in the control vs. collagen groups, respectively (P\<0.05).

Over the past decades, complete regeneration of the oral mucosa following surgery has been the focus of intense exploratory research. Allograft materials, such as acellular dermal matrix grafts, have been used as alternatives to avoid morbidity at the donor site. However, the complex interactions between the immune system and the artificial biomaterials used for oral soft tissue regeneration have not been thoroughly studied. The specific aim of the present study was to analyze for the first time the interactions between a resorbable 3D collagen matrix used for oral soft tissue regeneration and T cells, one of the most important immune players in the inflammatory microenvironment following oral soft tissue regenerative surgical procedures.

Apoptosis and migration of keratinocytes are vital for wound repair, and the T cells were demonstrated to ameliorate the wound-healing condition by increasing keratinocyte migration and proliferation and decreasing apoptosis of keratinocytes. More specifically, several subsets of T cells promote wound healing, which is a critical and complex process that occurs in the skin and other barrier sites. Activation of T cells at the injury site initiates massive infiltration of the wound with αβ T cells that likely facilitate the transition from the inflammatory to the proliferative phase of healing, and defects in dermal γδ T cells may be an important mechanism underlying delayed wound healing ([@b17-etm-0-0-6979]). A crucial role has been demonstrated for CD100-plexin B2 interactions in the wound healing response mediated by murine γδ T cells and in the T cell morphological changes associated with this process ([@b18-etm-0-0-6979]). T cell receptor ligands are not constitutively expressed in healthy tissues but are rapidly upregulated following wounding of keratinocytes bordering wound edges. Ligand expression is tightly regulated, with down-modulation following T cell activation. Early inhibition of T cell receptor-ligand interactions delays wound repair *in vivo*, highlighting T cells as rapid responders to injury ([@b19-etm-0-0-6979]).

The results of this study show that the T cell population increased significantly when exposed to 5-day incubation with the selected collagen matrix compared to cultured lymphocytes. Stimulating the overall T cell population suggests that the immune system\'s effector cell subsets are activated when in contact with the collagen scaffold. This increase was detected in all analyzed samples, with no connection with the initial immune status of the patient from which the sample was collected. We infer that the efficiency of tissue repair may be increased.

CD69 is a cell activation antigen present on active immune system cells in the very early stage of the lymphocyte activation process ([@b20-etm-0-0-6979],[@b21-etm-0-0-6979]). Lymphocytes usually have very low levels of CD69, but nearly all bone-marrow derived cells express the marker within the first 1--3 h following activation. Once upregulated, CD69 affects T cell differentiation and modulates the inflammatory response. Our data show that the CD69 surface marker increased significantly on cells in contact with the collagen matrix in all five samples, suggesting that the matrix initiates the appropriate immune response needed for tissue repair.

CD38 is another cell surface marker present on T cells and is responsible for cellular adhesion, migration, and local angiogenesis ([@b22-etm-0-0-6979],[@b23-etm-0-0-6979]). The marker is usually expressed during inflammatory processes and appears later in the wound healing process. In this study, CD38 levels decreased slightly but not significantly in the T cell group exposed to the collagen matrix compared to the controls. The marker displayed variations between patients, but the finding that expression was similar in both groups suggests that longer incubation times are needed for this marker to be significantly expressed. Future studies are necessary to assess the expression of CD38 on the T cell surface following exposure to collagen.

Our study also analyzed CD4 and CD8 as two key surface markers of the inflammatory process of wound healing. These markers are present in the wound at all four stages of wound healing and have their highest levels during the early phase of proliferation and the late phase of wound inflammation ([@b24-etm-0-0-6979],[@b25-etm-0-0-6979]). A decreased concentration of CD8 T cells and CD4 T cells can thus be associated with impaired or delayed wound healing. Our results show that CD8 increased significantly in the collagen sample cells, whereas CD4 levels were similar with the controls.

Annexin V is a 36 kDa protein with a high affinity for phosphatidylserine, which is located on the cytoplasmic surface of the cell membrane. During execution of the apoptotic program, phosphatidylserine is externalized, and the cells become rapidly positive for Annexin V ([@b26-etm-0-0-6979],[@b27-etm-0-0-6979]). Translocation of phosphatidylserine occurs on the external surface membrane during apoptosis and phosphatidylserine is exposed to the outside as the cell membrane is destroyed during necrosis and becomes a trigger for activation of macrophages. This phenomenon is also present in activated platelets, during mast cell degranulation, and in several erythrocyte abnormalities. In the presence of calcium ions, Annexin V binds with high affinity to phosphatidylserine exposed by apoptotic cells. The labeling technique using Annexin V conjugated with fluorochrome was developed to detect and identify apoptotic cell and dead T cells ([@b28-etm-0-0-6979]). A viability marker (PI) was used distinguish apoptotic cells from cells with a permeabilized plasma membrane during late non-apoptotic death, so that only apoptotic cells appeared positive for Annexin V, and double positive cells (Annexin V^+^/PI^+^) were eliminated from the statistics. Apoptotic cells are detected by staining with Annexin V, dead cells are identified by Annexin V and PI, while the viable cells cannot be detected by any of these markers ([@b29-etm-0-0-6979]). Our present results show that the selected 3D collagen matrix does not include T cells in early or late apoptosis. The percentage of viable cells was the same in the samples and controls. These findings demonstrate that the collagen matrix is nontoxic to immune system cells and does not hinder the healing process following periodontal surgery for soft tissue regeneration. A further study should address the compatibility of the collagen matrix with another important component of the healing process, the cells belonging to the epithelial compartment, namely epithelial cells. It is known that prolonged healing times or chronic inflammation can initiate or potentiate tumor processes both in the oral mucosa and in skin in general ([@b30-etm-0-0-6979]--[@b33-etm-0-0-6979]).

This study had several limitations that need to be addressed. One limitation is the limited number of clinical cases available for investigation. In addition, it can be difficult to associate the present *in vitro* results with the *in vivo* mechanisms responsible for the complex wound healing processes initiated after surgical placement of the xenogeneic collagen matrix. Another drawback is that the present results are based on a short 5-day incubation period. More studies involving larger groups of patients and longer incubation times of the collagen matrix are needed to better expand and explain the present findings.

In conclusion, the interaction between T cells and the 3D collagen matrix did not impair the healing process, it may accelerate oral wound healing following surgery, and increase the activity of immune system cells. However, these results need further research to fully explore the implications of the interactions between the resorbable 3D collagen matrix used for oral soft tissue regeneration and the T cells.
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Representative dot plots of unstimulated T cells (control) and collagen matrix-activated T cells. A representative dot plot for the unstimulated T cells (control) is shown in (A), and a representative dot plot for the collagen matrix-activated T cells is shown in (B), displaying an increase in the percentage of cytotoxic T cells.
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Representative dot plots for unstimulated T cells (control) and collagen matrix-activated T cells. A representative dot plot for the unstimulated T cells (control) is shown in (A), and a representative dot plot for the collagen matrix-activated T cells is shown in (B), displaying surface modifications of the CD69 activation marker.
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![Lymphocyte immunophenotypes: T and non-T cells were immunophenotyped. The unstimulated T cells were compared to collagen matrix-activated T cells following 5 days of incubation. \*P\<0.05.](etm-17-02-0990-g04){#f3-etm-0-0-6979}

![Lymphocyte viability: Τhe viability of unstimulated T cells, expressed as percentage of total cells, was compared to the viability of collagen matrix-activated T cells. Cells in late stages of apoptosis of necrosis were included in the cell death/cellular death levels.](etm-17-02-0990-g05){#f4-etm-0-0-6979}
